Knowledge Library - Practice
Dr. Jeff Gudin discusses whether patients can build a tolerance to opioid-induced constipation.
In this video, Dr. Chris Herndon discusses the risk factors for developing opioid-induced constipation.
Dr. Jeff Gudin discusses the newer agents available for opioid-induced constipation and the possible adverse effects these medications can cause.
In this video, Dr. Jeff Gudin discusses current standards of care in opioid-induced constipation.
Dr. Chris Herndon discusses how to assess for opioid-induced constipation.
In this video, Dr. Kathryn Hahn discusses whether prescription drug monitoring programs can be accessed across states.
In this video, Dr. Kathryn Hahn discusses whether all prescription drug monitoring programs are operationally the same.
In this video, Dr. Kenneth Kirsh discusses whether patients require a treatment agreement regardless of their assessed risk level.
In this video, Dr. Lynn Webster discusses whether the display of aberrant behavior in a patient can be assumed as abuse.
In this video, Dr. Kathryn Hahn discusses how often the PDMPs should be accessed, whether it is after each prescription or periodically.